Showing 4641-4660 of 7110 for: Cochrane Systematic Reviews Back
- Ovulation triggers in anovulatory women undergoing ovulation induction
Cochrane Systematic Reviews, 21-Mar-2014
Anovulation is a common cause of infertility. Drugs used to treat anovulation include selective oestrogen receptor modulators, aromatase inhibitors and gonadotrophins. Ovulation triggers are used with these drugs, as a surrogate for the hormonal surge see
- Oxatomide for stable asthma in adults and children
Cochrane Systematic Reviews, 5-Jun-2014
Oxatomide is a histamine H1-receptor antagonist. As an oral agent, oxatomide may be useful in managing asthma. Some guidelines recommend oxatomide for long-term prophylaxis of asthma in children. There is no clear evidence whether children or adults with
- Oxcarbazepine add‐on for drug‐resistant focal epilepsy
Cochrane Systematic Reviews, 4-Mar-2020
Epilepsy is a common neurological disorder. In approximately 30% of epilepsy cases, seizures are uncontrolled by one antiepileptic drug (AED). These people require treatment with a combination of multiple AEDs and are described as having drug-resistant ep
- Oxcarbazepine add-on for drug-resistant partial epilepsy
Cochrane Systematic Reviews, 20-Oct-2008
Most people with epilepsy have a good prognosis and their seizures can be well controlled with the use of a single antiepileptic drug, but up to 30% develop refractory epilepsy, especially those with partial seizures. In this review we summarize the curre
- Oxcarbazepine for acute affective episodes in bipolar disorder
Cochrane Systematic Reviews, 9-Nov-2011
Oxcarbazepine, a keto derivative of the ‘mood stabiliser’ carbamazepine, may have efficacy in the treatment of acute episodes of bipolar disorder. Potentially, it may offer pharmacokinetic advantages over carbamazepine.
- Oxcarbazepine for neuropathic pain
Cochrane Systematic Reviews, 11-Nov-2013
Neuropathic pain is difficult to treat. Oxcarbazepine is an anticonvulsant drug closely related to carbamazepine and is reportedly better tolerated. Oxcarbazepine has been reported to be efficacious in the treatment of neuropathic pain.
- Oxcarbazepine in the maintenance treatment of bipolar disorder
Cochrane Systematic Reviews, 2-Nov-2008
Some studies have suggested that oxcarbazepine has a role in preventing episode recurrence in bipolar affective disorder. This review attempted to investigate the existing evidence from randomised controlled trials for its use in the maintenance treatment
- Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Systematic Reviews, 11-Aug-2009
Partial onset seizures are often treated with the standard antiepileptic drug carbamazepine. Oxcarbazepine is a newer antiepileptic drug related to carbamazepine that is claimed to be better tolerated.
- Oxcarbazepine versus phenytoin monotherapy for epilepsy
Cochrane Systematic Reviews, 2-Apr-2013
This is an updated version of the original Cochrane review published in The Cochrane Library 2006, Issue 2.
- Oximes for acute organophosphate pesticide poisoning
Cochrane Systematic Reviews, 18-Jan-2011
Acute organophosphorus pesticide poisoning causes tens of thousands of deaths each year across the developing world. Standard treatment involves administration of intravenous atropine and oxime to reactivate inhibited acetylcholinesterase. The clinical us
- Oxycodone for cancer‐related pain
Cochrane Systematic Reviews, 9-Jun-2022
Many people with cancer experience moderate to severe pain that requires treatment with strong opioids, such as oxycodone and morphine. Strong opioids are, however, not effective for pain in all people, neither are they well tolerated by all people. The a
- Oxycodone for neuropathic pain and fibromyalgia in adults
Cochrane Systematic Reviews, 3-Jul-2014
This review is one of a series on drugs used to treat neuropathic pain and fibromyalgia. These conditions are estimated to affect 3 to 10% of adults, and are difficult to treat. Although they probably have different aetiologies, neuropathic pain and fibro
- Oxygen therapy during exercise training in chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 11-Jun-2009
Exercise training within the context of pulmonary rehabilitation improves outcomes of exercise capacity, dyspnea and health-related quality of life in individuals with chronic obstructive pulmonary disease (COPD). Supplemental oxygen in comparison to plac
- Oxygen therapy for acute myocardial infarction
Cochrane Systematic Reviews, 13-Aug-2013
Oxygen (O2) is widely used in people with acute myocardial infarction (AMI) although it has been suggested it may do more harm than good. Previous systematic reviews have concluded that there was insufficient evidence to know whether oxygen reduced, incre
- Oxygen therapy for cystic fibrosis
Cochrane Systematic Reviews, 4-Jul-2013
The most serious complications of cystic fibrosis (CF) relate to respiratory insufficiency. Oxygen supplementation therapy has long been a standard of care for individuals with chronic lung diseases associated with hypoxemia. Physicians commonly prescribe
- Oxygen therapy for dyspnoea in adults
Cochrane Systematic Reviews, 20-Nov-2013
Dyspnoea, or distressing breathing, is often a severe subjective symptom in terminal illness and may be difficult to control. Oxygen therapy is currently one of the interventions used to treat it. This review aimed to identify all randomised controlled st
- Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age
Cochrane Systematic Reviews, 10-Dec-2014
Treatment for lower respiratory tract infections (LRTIs) includes administering complementary oxygen. The effectiveness of oxygen therapy and of different delivery methods remains uncertain.
- Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 21-Sep-2008
Chronic obstructive pulmonary disease (COPD), a leading cause of morbidity and mortality in the developed world, is characterised by acute deterioration in symptoms. During these exacerbations, people are prone to developing alveolar hypoventilation, whic
- Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries
Cochrane Systematic Reviews, 11-Jul-2013
The rate of operative deliveries (both caesarean sections, vacuum extractions and forceps), continues to rise throughout the world. These are associated with significant maternal and neonatal morbidity. The most common reasons for operative births in null
- Oxytocin for prelabour rupture of membranes at or near term
Cochrane Systematic Reviews, 6-Nov-2008
Induction of labour after prelabour rupture of membranes may reduce the risk of neonatal infection.